JSJehangir Ali Shah

Jehangir Ali Shah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jehangir Ali Shah has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Significance of On-admission Impaired Estimated Glomerular Filtration Rate for the Assessment of Immediate Outcomes after Percutaneous Coronary Intervention

    by Khalid Iqbal Bhatti, Kamran Ahmed Khan, Jehangir Ali Shah, Bashir Ahmed Solangi, Salik Ahmed, Ahsan Ali, Sanjana Karera, Kalsoom Chachar, Fawad Farooq, Jawaid Akbar Sial

    Objectives: Impaired baseline estimated glomerular filtration rate (eGFR) has been associated with a heightened risk of major adverse clinical events (MACE) following percutaneous coronary intervention (PCI). Early recognition of renal dysfunction on admission can help optimize clinical decision-making and improve post-PCI outcomes. This study aimed to evaluate the prognostic significance of baseline eGFR among patients with acute myocardial infarction (AMI) and its impact on immediate in-hospital outcomes after PCI. Methodology: We enrolled adult AMI patients undergoing PCI and calculated their baseline eGFR (ml/min/1.73 m²). In-hospital MACE was recorded for all patients. Participants were stratified into three groups based on eGFR values: ≥60, 45–59, and <45 ml/min/1.73 m². Results: Among 296 patients (mean age: 56.8 ± 10.8 years; 87.5% male), eGFR distribution was as follows: ≥60 in 75.3%, 45–59 in 12.8%, and <45 in 11.8%. Overall, MACE occurred in 5.7% (17 patients). The incidence of MACE was significantly higher in patients with reduced eGFR (p=0.005), observed in 3.6% of patients with eGFR ≥ 60, 7.9% with eGFR 45–59, and 17.1% with eGFR <45. In multivariable analysis, Killip class III or IV and final TIMI (thrombolysis in myocardial infarction) flow < III were identified as independent predictors of in-hospital MACE (adjusted odds ratios [ORs]: 3.81 [95% confidence interval (CI): 1.01–14.36] and 7.17 [95% CI: 2.08–24.68], respectively), while eGFR did not reach statistical significance. Conclusion: Reduced baseline eGFR was associated with a higher incidence of in-hospital MACE following PCI in AMI patients. However, after adjusting for confounders, Killip class III or IV and suboptimal final TIMI flow were more robust independent predictors of immediate adverse outcomes. Methodology: We enrolled adult AMI patients undergoing PCI and calculated their baseline eGFR (ml/min/1.73 m²). In-hospital MACE was recorded for all patients. Participants were stratified into three groups based on eGFR values: ≥60, 45–59, and <45 ml/min/1.73 m². Results: Among 296 patients (mean age: 56.8 ± 10.8 years; 87.5% male), eGFR distribution was as follows: ≥60 in 75.3%, 45–59 in 12.8%, and <45 in 11.8%. Overall, MACE occurred in 5.7% (17 patients). The incidence of MACE was significantly higher in patients with reduced eGFR (p=0.005), observed in 3.6% of patients with eGFR ≥ 60, 7.9% with eGFR 45–59, and 17.1% with eGFR <45. In multivariable analysis, Killip class III or IV and final TIMI (thrombolysis in myocardial infarction) flow < III were identified as independent predictors of in-hospital MACE (adjusted odds ratios [ORs]: 3.81 [95% confidence interval (CI): 1.01–14.36] and 7.17 [95% CI: 2.08–24.68], respectively), while eGFR did not reach statistical significance. Conclusion: Reduced baseline eGFR was associated with a higher incidence of in-hospital MACE following PCI in AMI patients. However, after adjusting for confounders, Killip class III or IV and suboptimal final TIMI flow were more robust independent predictors of immediate adverse outcomes.

  • Open Access

    Clinical Predictors of Revascularization in Patients with Aborted Myocardial Infarction

    by Salik Ahmed, Sanam Khowaja, Shahzad Khatti, Muhammad Tariq Sallar, Saher Khowaja, Rajesh Kumar, Jehangir Ali Shah, Jawaid Akbar Sial

    Objectives: The objective of this study was to evaluate the clinical and angiographic profiles of patients with aborted myocardial infarction (MI) and to identify the revascularization strategy for these patients. Methodology: A total of 120 consecutive patients with aborted MI, undergoing immediate revascularization at a tertiary care cardiac center, were included in the study. Aborted MI was defined as the spontaneous resolution of ST-segment elevation by >70% on consecutive ECGs before the administration of definitive reperfusion therapy. Patients were categorized into two groups: reperfusion therapy (RT) and recanalized vessels (RV) group. The RT group included patients who underwent plain old balloon angioplasty (POBA) or stent deployment. Results: Among the 120 patients, 85.8% (103) were male, with a mean age of 48.91±11.62 years. Recanalized vessels were observed in 36.7% (44) of the patients. Compared to the RT group, patients in the RV group were relatively younger (43.41±12.68 vs. 52.09±9.7 years; p<0.001). A significantly higher proportion of patients in the RV group had anterior wall MI (AWMI) (67.1% vs. 9.5%; p<0.001) and a shorter median chest pain-to-ACS protocol time (180 [120-255] vs. 300 [180-360] minutes; p=0.003). Multivariable regression analysis identified AWMI as an independent predictor of the need for immediate revascularization, with an adjusted odds ratio of 5.74 [95% CI: 2.33-14.16]. Conclusion: Our study concludes that patients with aborted MI can be classified based on their clinical profiles to determine the timing and strategy of revascularization. Patients were categorized into two groups: those with recanalized vessels (RV) on angiography and those requiring revascularization therapy (RT), either POBA or stent deployment. Several predictors, such as younger age at presentation, type 2 diabetes mellitus, smoking, family history of premature coronary artery disease, dyslipidemia, and the time elapsed after chest pain onset, can help pre-classify patients into high-risk categories requiring immediate revascularization or low-risk categories eligible for early invasive strategies.

  • Open Access

    Factors Associated with Elevated Left Ventricular End-Diastolic Pressure in Patients Undergoing Primary Percutaneous Coronary Intervention

    by Ahsan Ali, Bashir Ahmed Solangi, Jehangir Ali Shah, Ghulam Shabbir Shar, Zafar Iqbal, Khalil Ahmed Shaikh, Gulzar Ali, Mahesh Kumar Batra, Muhammad Naeem Mengal, Ambreen Nisar, et al.

    Objectives: The prognostic value of left ventricular end-diastolic pressure (LVEDP) in patients with ST-segment elevation myocardial infarction (STEMI) is well-established. However, data regarding clinical factors associated with elevated LVEDP remain limited. This study aimed to evaluate the clinical indicators and patient phenotype associated with elevated LVEDP among STEMI patients undergoing primary percutaneous coronary intervention (PCI), to aid individualized risk stratification. Methodology: This descriptive cross-sectional study enrolled patients diagnosed with STEMI who underwent primary PCI. LVEDP was measured using a fluid-filled pigtail catheter post-angiography but prior to reperfusion. Elevated LVEDP was defined as >25 mmHg. Results: A total of 498 patients were included, of which 23.7% (n=118) were female, with a mean age of 53.7 ± 11.7 years. LVEDP distribution was as follows: ≤15 mmHg in 48% (n=239), 15–25 mmHg in 42% (n=209), and >25 mmHg in 10% (n=50) of the patients. Elevated LVEDP was significantly associated with increased heart rate (adjusted odds ratio [aOR] 1.05 [1.02–1.08]), decreased systolic blood pressure (aOR 0.95 [0.90–0.99]), Killip class ≥II (aOR 9.36 [3.38–25.90]), and history of hypertension (aOR 4.63 [1.55–13.82]). Conclusion: Clinical indicators such as elevated heart rate, reduced systolic blood pressure, higher Killip class, and hypertension are significantly associated with elevated LVEDP in STEMI patients. Early identification of these factors may aid in hemodynamic risk assessment during primary PCI.

  • Open Access

    Reply

    by Jehangir Ali Shah, Musa Karim, Abdul Hakeem

  • Open Access

    Rivaroxaban vs Warfarin in Acute Left Ventricular Thrombus Following Myocardial Infarction

    by Jehangir Ali Shah, Jamil Hussain, Bashir Ahmed, Mahesh Kumar Batra, Gulzar Ali, Mariam Naz, Waqar Khan, Khalid Iqbal Bhatti, Musa Karim, Abdul Hakeem


  • Open Access

    One-year major adverse cardiovascular events among same-day discharged patients after primary percutaneous coronary intervention at a tertiary care cardiac centre in Karachi, Pakistan: a prospective observational study

    by Jehangir Ali Shah, Rajesh Kumar, Bashir Ahmed Solangi, Kamran Ahmed Khan, Tarique Ahmed, Sanam Khowaja, Gulzar Ali, Mehwish Zehra, Jawaid Akbar Sial, Musa Karim, et al.

    Objective Knowledge regarding the short-term outcomes after same-day discharge (SDD) post primary percutaneous coronary intervention (PCI) is lacking. In this study, we evaluated 1-year major adverse cardiovascular events (MACE) among SDD patients after primary PCI. Design 1-year follow-up analysis of a subset of patients from an existing prospective cohort study. Setting Tertiary care cardiac hospital in Karachi, Pakistan. Participants Consecutive patients, from August 2019 to July 2020, with ST segment elevation myocardial infarction who had undergone primary PCI with SDD (within 24 hours) after the procedure by the treating physician and with at least one successful follow-up up to 1 year. Outcome measure Cumulative MACE during follow-up at the intervals of 1 week, 1 month, 6 months and 1 year. Results 489 patients were included, with a gender distribution of 83.2% (407) male patients and a mean age of 54.58±10.85 years. Overall MACE rate during the mean follow-up duration of 326.98±76.71 days was 10.8% (53), out of which 26.4% (14/53) events occurred within 6 months of discharge and the remaining 73.6% (39/53) occurred between 6 months and 1 year. MACE was significantly higher among patients with a Zwolle Risk Score (ZRS) ≥4 at baseline, with an incidence rate of 21.9% (16/73) vs 8.9% (37/416; p=0.001) in patients with ZRS≤3 (relative risk 2.88 (95% CI 1.5 to 5.5)). Conclusion A significant burden of short-term MACE was identified among SDD patients after primary PCI; most of these events occurred after 6 months of SDD, mainly among patients with ZRS≥4. A systematic risk assessment based on risk stratification modalities such ZRS could be a viable option for SDD patients with primary PCI.


  • Open Access

    Incidence, Predictors, and Outcomes of Acute and Sub-acute Stent Thrombosis after Emergency Percutaneous Coronary Revascularization with Drug-Eluting Stents: A Prospective Observational Study

    by Rajesh Kumar, Ali Ammar, Tahir Saghir, Jawaid Akbar Sial, Jehangir Ali Shah, Ashok Kumar, Abdul Hakeem Shaikh, Abdul Samad Achakzai, Nadeem Qamar, Musa Karim

    Stent thrombosis (ST) remains the most feared complication of percutaneous coronary intervention (PCI). Therefore, this study aimed to determine acute and sub-acute ST incidence, predictors, and outcomes after primary PCI. This prospective observational study included patients who had undergone primary PCI at a tertiary care cardiac center. All the patients were followed at 30-days of index hospitalization for the incidence of acute or sub-acute ST. ST was further categorized as definite, probable, or possible per the Academic Research Consortium definition. All the survivors of ST were followed after 6-months for the incidence of major adverse cardiovascular events. An aggregate of 1756 patients were included with 79% (1388) male patients and mean age was 55.59 ± 11.23 years. The incidence of ST was 4.9% (86) with 1.3% (22) acute and 3.6% (64) sub-acute. ST was categorized as definite in 3.3% (58) and probable in 1.6% (28). Independent predictor of ST were observed to be male gender (odds ratio (OR); 2.51 [1.21–5.2]), left ventricular end-diastolic pressure ≥20 mmHg (OR; 2.55 [1.31–4.98]), and pre-procedure thrombolysis in myocardial infarction (TIMI) flow 0 (OR; 3.27 [1.61–6.65]). Cumulative all-cause mortality among patients with ST after 164.1 ± 76.2 days was 46.5% (40/86). We observed a substantial number of patients vulnerable to the acute or sub-acute ST after primary PCI. Male gender, LVEDP, pre-procedure TIMI flow grade can be used to identify and efficiently manage highly vulnerable patients.


  • Open Access

    CHA2DS2-VASc, a Simple Clinical Score Expanding Its Boundaries to Predict Contrast-Induced Acute Kidney Injury After Primary Percutaneous Coronary Interventions

    by Rajesh Kumar, Mahesh Kumar Batra, Sanam Khowaja, Ali Ammar, Ashok Kumar, Jehangir Ali Shah, Jawaid Akbar Sial, Tahir Saghir, Musa Karim

    Objective: Promising results of CHA2DS2-VASc score have been reported for the prediction of contrast-induced acute kidney injury (CI-AKI) after percutaneous coronary intervention (PCI). However, data of its predictive strength in the context of primary PCI are not available. Therefore, in this study, we have assessed predictive value of CHA2DS2-VASc score for CI-AKI after primary PCI. Methods: This analytical cross-sectional study was conducted between January 2021 and June 2021 at the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan. Inclusion criteria of the study was consecutive adult patients who had undergone primary PCI. Baseline CHA2DS2-VASc score was calculated, and either a 25% or 0.5 mg/dL increase in post-procedure serum creatinine level as compared to baseline level was categorized as CI-AKI. Results: A total of 691 patients were included, of which 82.1% (567) were male. CI-AKI after primary PCI was observed in 63 (9.1%) patients, out of which 66.7% (42) of patients had CHA2DS2-VASc score of ≥ 2. The area under the curve (AUC) for the score was 0.725 [0.662 to 0.788] with a sensitivity and specificity of 66.7% [63.1% to 70.2%] and 66.7% [53.7% to 78.1%], respectively, at a cut-off value of ≥ 2. In multivariable analysis, left ventricular ejection fraction ≤ 30% and CHA2DS2-VASc ≥ 2 were found to be independent predictors with adjusted odds ratios of 2.19 [1.06– 4.5] and 2.13 [1.13– 4.01], respectively. Conclusion: CHA2DS2-VASc score has a good predictive value for the prediction of CI-AKI after primary PCI. Criteria of CHA2DS2-VASc ≥ 2 can be used for the risk stratification of CI-AKI after primary PCI.


  • Open Access

    Zwolle Risk Score for Safety Assessment of Same-Day Discharge after Primary Percutaneous Coronary Intervention

    by Jehangir Ali Shah, Bashir Ahmed Solangi, Mahesh Kumar Batra, Kamran Ahmed Khan, Ghazanfar Ali Shah, Gulzar Ali, Mehwish Zehra, Muhammad Hassan, Muhammad Zubair, Musa Karim

    Objectives: The Zwolle risk score (ZRS) has been considered to be a useful tool for the systematic evaluation of patients for early discharge after primary percutaneous coronary intervention (PCI). Therefore, aim of this study was to evaluate the clinical utility of ZRS for the same-day discharge strategy after primary PCI at a tertiary care cardiac center of Karachi, Pakistan. Methods: This study was conducted at a tertiary care cardiac center between August 2019 and July 2020. Patients discharged within 24 hours (same-day) of the primary PCI procedure were included. Patients were stratified as high- and low-risk based on ZRS score; low-risk (≤3) and high-risk (≥4). All patients were followed during 30-days post-procedure period for major adverse cardiac events (MACE). Results: Out of 487 patients, 83.2% (405) were male and mean age was 54.6 ± 10.87 years. Mean ZRS was 2.34 ± 1.64 with 16.0% (78) patients in high-risk (≥4) group. 30-days MACE rate was observed to be 5.3% (26) with significantly higher rate among high-risk patients as compared to low-risk patients 12.8% (10) vs. 3.9% (16); p=0.004 respectively with OR of 3.61 [1.57 - 8.29]. The area under the curve (AUC) of ZRS for prediction of 30-day MACE was 0.67 [95% CI: 0.58-0.77], ZRS ≥4 had sensitivity of 38.5% and specificity of 85.2% with AUC of 0.62 [95% CI: 0.50-0.74] for prediction of 30-day MACE. Conclusion: ZRS showed moderate discriminating potential in identifying patients with high-risk of MACE at 30-day after same-day discharge after primary PCI.


  • Open Access

    Safety and Feasibility of Same Day Discharge Strategy for Primary Percutaneous Coronary Intervention

    by Jehangir Ali Shah, Tahir Saghir, Bashir Ahmed, Syed Alishan Ul Haq, Rajesh Kumar, Muhammad Naeem Mengal, Mehwish Zehra, Syeda Sakeena Raza, Musa Karim, Nadeem Qamar

    The strategy for early discharge after primary percutaneous coronary intervention (PCI) could have substantial financial benefits, especially in low-middle income countries. However, there is a lack of local evidence on feasibility and safety of the strategy for early discharge. Therefore, the aim of this study was to assess the safety of early discharge after primary PCI in selected low-risk patients in the population of Karachi, Pakistan. In this study 600 consecutive low-risk patients who were discharged within 48 hours of primary PCI were put under observation for major adverse cardiac events (MACE) after 7 and 30 days of discharge respectively. Patients were further stratified into discharge groups of very early (≤ 24 hours) and early (24 to 48 hours). The sample consisted of 81.8% (491) male patients with mean age of 54.89 ± 11.08 years. Killip class was I in 90% (540) of the patients. The majority of patients (84%) were discharged within 24 hours of the procedure. Loss to follow-up after rate at 7 and 30 days was 4% (24) and 4.3% (26) respectively. Cumulative MACE rate after 7 and 30 days was observed in 3.5% and 4.9%, all-cause mortality in 1.4% and 2.3%, cerebrovascular events in 0.9% and 1.4%, unplanned revascularization in 0.9% and 1.2%, re-infarction in 0.3% and 0.5%, unplanned re-hospitalization in 0.5% and 0.5%, and bleeding events in 0.5% and 0.5% of the patients respectively. It was observed that very early (≤ 24 hours) discharge after primary PCI for low-risk patients is a safe strategy subjected to careful pre-discharge risk assessment with minimal rate of MACE after 7-days as well as 30-days.